Small cell lung cancer (SCLC) is a fast-growing type of lung cancer. It spreads much more quickly than non-small cell lung cancer.
There are three different types of small cell lung cancer:
- Small cell carcinoma (oat cell cancer)
- Mixed small cell/large cell carcinoma
- Combined small cell carcinoma
Most small cell lung cancers are the oat cell type.
Cancer - lung - small cell; Small cell lung cancer; SCLC
About 15% of all lung cancer cases are small cell lung cancer. Small cell lung cancer is slightly more common in men than women.
Almost all cases of SCLC are due to cigarette smoking. SCLC is rare in those who have never smoked.
SCLC is the most aggressive form of lung cancer. It usually starts in the breathing tubes (bronchi) in the center of the chest. Although the cancer cells are small, they grow very quickly and create large tumors. These tumors often spread rapidly (metastasize) to other parts of the body, including the brain, liver, and bone.
Other symptoms that may occur with this disease:
Your health care provider will perform a physical exam and ask questions about your medical history. You will be asked whether you smoke, and if so, how much and for how long you have smoked.
When listening to your chest with a stethoscope, your health care provider can sometimes hear fluid around the lungs or areas of partial lung collapse. Each of these findings could (but does not always) suggest cancer.
Small cell lung cancer has usually spread to other parts of your body by the time it is diagnosed.
Tests that may be performed include:
In some cases, your health care provider may need to remove a piece of tissue from your lungs for examination under a microscope. This is called a biopsy. There are several ways to do this:
Usually, if a biopsy reveals cancer, more imaging tests are done to find out the stage of the cancer. (Stage means how big the tumor is and how far it has spread.) However, the traditional staging system, which uses numbers to tell how advanced the cancer is, is usually not used for patients with SCLC. Instead, SCLC is classified as either:
- Limited (cancer is only in the chest and can be treated with radiation therapy)
- Extensive (cancer has spread outside the chest)
The majority of cases are extensive.
For additional information and resources, see cancer support group.
How well you do depends on how much the lung cancer has spread.
Without treatment, the average survival is 2 -4 months. Treatment can often prolong life to 6 - 12 months in patients with extensive disease. About 10% of patients with limited spread will show no evidence of cancer at 2 years.
This type of cancer is very deadly. Only about 6% of people with this type of cancer are still alive 5 years after diagnosis.
Call your health care provider if you have symptoms of lung cancer (particularly if you smoke).
Because SCLC spreads quickly throughout the body, treatment must include cancer-killing drugs (chemotherapy) taken by mouth or injected into the body.
- Chemotherapy may be combined with radiation therapy of the lungs in people who have limited disease.
- The most commonly used drugs in the U.S. are etoposide with either cisplatin or carboplatin.
Because the disease has usually spread by the time it is diagnosed, very few patients with SCLC are helped by having surgery. Surgery is only considered when there is only one tumor that has not spread. Chemotherapy or radiation will be needed after surgery.
Combination chemotherapy and radiation treatment is given to people with extensive SCLC. However, the treatment only helps relieve symptoms. It does not cure the disease.
Often, SCLC may have already spread to the brain, even when there are no symptoms or other signs of cancer in the brain. As a result, radiation therapy to the brain may be given to some patients with smaller cancers, or to those who had a good response in the first round of chemotherapy. This method is called prophylactic cranial irradiation (PCI).
If you smoke, stop smoking. It's never too late to quit. In addition, you should try to avoid secondhand smoke.
Routine screening for lung cancer is not recommended. Many studies have been done to look at this idea, but physicians have concluded that, at this time, screening would not help improve a person's chance for a cure.
Ettinger DS. Lung cancer and other pulmonary neoplasms. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 201.
National Cancer Institute. Small cell lung cancer treatment PDQ. Updated February 13, 2009.
U.S. Preventive Services Task Force. Lung cancer screening. Ann Int Med. 2004;140:738-739.
Review Date: 8/9/2009
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2009 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.